Natixis Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$321K Sell
15,326
-5,751
-27% -$130K ﹤0.01% 1638
2025
Q4
$485K Buy
21,077
+1,498
+8% +$49.3K ﹤0.01% 1451
2025
Q3
$589K Sell
19,579
-27,290
-58% -$818K ﹤0.01% 1448
2025
Q2
$1.7M Buy
46,869
+23,363
+99% +$842K ﹤0.01% 1138
2025
Q1
$851K Sell
23,506
-27,404
-54% -$1.14M ﹤0.01% 1317
2024
Q4
$2.14M Sell
50,910
-1,652
-3% -$82K ﹤0.01% 1075
2024
Q3
$2.92M Buy
52,562
+39,086
+290% +$1.99M 0.01% 977
2024
Q2
$554K Sell
13,476
-218
-2% -$9.31K ﹤0.01% 1413
2024
Q1
$639K Sell
13,694
-1,595
-10% -$75.2K ﹤0.01% 1333
2023
Q4
$731K Buy
15,289
+1,496
+11% +$58K ﹤0.01% 1302
2023
Q3
$492K Sell
13,793
-1,957
-12% -$77.5K ﹤0.01% 1361
2023
Q2
$727K Buy
15,750
+4,492
+40% +$208K ﹤0.01% 1242
2023
Q1
$451K Buy
11,258
+1,016
+10% +$43.6K ﹤0.01% 1331
2022
Q4
$475K Buy
+10,242
New +$403K ﹤0.01% 1304

Other funds holding RARE